PatternsRadar
Sign in

UNICHEMLABUnichem Laboratories Limited

NSE
468.95INR-10.30 (-2.15%)Close · 20 Nov 2026
4 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹3,302 CrMarket cap
9.7P/E (TTM)
55.4%Delivery

Filings & corporate actions

79 results filed
CSV
Next results · Q3 FY27
Expected 29 Jan 2027 – 6 Feb 2027
Estimate: filed 29–37 days after quarter end, last 5 times
Dividend
₹4.00 per share · last 1 Aug 2022
2026
  • 4 NovresultsResults · Q2 FY27 · consolidated and standalone+0.4%NSE
  • 13 OctshareholdingShareholding · 30 Sept 2026-0.7%NSE
  • 11 AugresultsResults · Q1 FY27 · consolidated and standalone+13.1%NSE
  • 14 JulshareholdingShareholding · 30 Jun 2026-2.6%NSE
  • 22 MayresultsResults · Q4 FY26 · consolidated and standalone-3.1%NSE
  • 13 AprshareholdingShareholding · 31 Mar 2026+0.3%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone-7.8%NSE
  • 9 JanshareholdingShareholding · 31 Dec 2025-1.2%NSE

Reaction to results · all yearsrose on day 0 in 28 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY274 Nov 2026+0.4%+0.9%—9.8×
Q1 FY2711 Aug 2026+13.1%+4.4%+9.6%26.8×
Q4 FY2622 May 2026-3.1%-1.6%+17.6%3.4×
Q3 FY265 Feb 2026-7.8%-12.6%-27.7%3.2×
Q2 FY2611 Nov 2025+4.3%+3.2%-4.0%24.2×
Q1 FY264 Aug 2025-7.4%-18.7%-17.5%5.0×
Q4 FY2522 May 2025+2.6%-4.4%-6.3%3.9×
Q3 FY256 Feb 2025+1.4%-4.1%-5.2%16.9×
Q2 FY2513 Nov 20240.0%-2.2%-11.1%2.6×
Q1 FY258 Aug 2024-3.3%-3.8%-2.0%2.0×
Q4 FY2422 May 2024-3.1%-4.4%-5.8%1.2×
Q3 FY245 Feb 2024+20.0%+7.8%+12.1%27.8×
Q2 FY241 Nov 2023-4.2%-7.4%-3.4%1.5×
Q1 FY2414 Jul 2023+1.5%+0.4%+7.4%6.2×
Q4 FY2323 May 2023+0.2%+0.3%-0.8%1.0×
Q3 FY236 Feb 2023-1.2%+0.6%-3.8%0.6×
Q2 FY2311 Nov 2022-2.3%+8.6%-22.4%0.6×
Q1 FY239 Aug 2022-9.2%-2.4%+22.6%4.7×
Q4 FY2227 May 2022+13.7%+3.9%+0.6%21.7×
Q3 FY2229 Jan 2022-4.4%-11.7%-9.2%0.9×
Q2 FY223 Nov 2021-2.1%-6.8%+12.0%1.6×
Q1 FY2231 Jul 2021-5.8%-12.9%-12.4%3.1×
Q4 FY2129 May 2021-6.5%-8.8%-11.0%1.8×
Q3 FY2130 Jan 2021+1.3%+14.0%+12.2%0.7×
Q2 FY211 Nov 2020-1.7%-7.1%+0.8%3.5×
Q1 FY214 Aug 2020-2.0%-9.7%-8.1%1.9×
Q4 FY2020 Jun 2020-1.6%+10.5%+29.1%0.8×
Q3 FY203 Feb 2020-3.5%-5.9%-16.2%1.1×
Q2 FY202 Nov 2019-4.7%-14.2%-12.5%1.4×
Q1 FY2027 Jul 2019-3.1%-0.7%-1.4%2.4×
Q4 FY1924 May 2019-3.4%-3.5%-13.4%1.8×
Q3 FY196 Feb 2019+1.4%-3.9%-0.9%3.4×
Q2 FY199 Nov 2018-1.8%-3.0%-13.5%1.1×
Q1 FY197 Aug 2018-2.5%-6.1%+2.2%0.5×
Q4 FY1827 Jun 2018-0.6%+1.1%-3.0%0.4×
Q3 FY189 Jan 20180.0%+0.7%+3.6%0.6×
Q2 FY186 Nov 2017-4.5%-6.7%-4.2%1.2×
Q1 FY1818 Aug 2017-1.6%-2.8%+0.6%0.2×
Q4 FY1719 Jun 2017-1.0%-1.4%+3.6%0.5×
Q3 FY1723 Jan 2017+0.1%-1.7%-7.1%1.5×
Q2 FY1724 Oct 2016+0.5%+1.6%-10.5%0.4×
Q1 FY171 Oct 2016+5.8%+8.8%+5.4%5.8×
Q4 FY1623 May 2016-0.5%-2.6%-3.6%1.1×
Q3 FY1627 Jan 2016-2.1%-7.6%-17.0%1.5×
Q2 FY1619 Oct 2015-4.0%-7.4%-7.2%0.7×
Q1 FY1613 Jul 2015+2.8%+13.8%+8.4%2.0×
Q4 FY1511 May 2015-0.8%-0.5%-11.4%0.8×
Q3 FY1519 Jan 2015-3.4%-3.3%-6.7%4.2×
Q2 FY1521 Oct 2014-0.9%-2.0%+16.7%0.8×
Q1 FY1514 Jul 2014-3.8%+1.8%+11.2%1.2×
Q4 FY1412 May 2014+1.3%-6.5%-2.8%1.9×
Q3 FY1420 Jan 2014-0.5%-5.8%-5.2%1.2×
Q2 FY1421 Oct 2013-0.4%+2.7%+13.9%1.9×
Q1 FY1423 Jul 2013+0.6%+1.7%-7.7%0.6×
Q4 FY1321 May 2013-1.1%-7.9%-8.9%0.2×
Q3 FY1318 Jan 2013-5.9%-6.9%-13.0%1.6×
Q2 FY1322 Oct 2012+4.7%-0.7%-8.7%4.1×
Q1 FY1324 Aug 2012-0.4%-0.7%+16.9%0.4×
Q4 FY1214 May 2012+0.9%+1.1%-1.2%0.7×
Q3 FY1223 Jan 2012-4.2%-4.7%-8.0%0.3×
Q2 FY1222 Oct 2011-2.5%-4.4%-20.9%0.7×
Q1 FY1228 Jul 2011-3.1%-1.3%-4.1%1.4×
Q4 FY1114 May 2011-3.0%-7.8%-12.9%1.2×
Q3 FY1117 Jan 2011-3.4%-3.0%-3.4%1.1×
Q2 FY1118 Oct 2010-5.1%+0.6%+11.8%1.6×
Q1 FY1122 Jul 2010-3.0%-6.1%-10.4%5.1×
Q4 FY1010 May 2010+1.2%+0.8%+9.6%1.2×
Q3 FY1019 Jan 2010+3.6%+1.1%-0.3%1.5×
Q2 FY1022 Oct 2009-1.2%-3.8%-4.4%3.2×
Q1 FY1022 Jul 2009+1.4%+3.8%+0.6%1.3×
Q4 FY0921 May 2009+0.4%+18.6%+6.1%2.2×
Q3 FY0922 Jan 2009+3.8%-2.5%-6.9%10.0×
Q2 FY0923 Oct 2008+0.9%-1.1%-2.7%1.3×
Q1 FY0917 Jul 2008+14.1%+8.0%+26.0%16.5×
Q4 FY0812 May 2008-1.5%+8.4%+1.6%2.0×
Q3 FY0831 Jan 2008-1.1%-4.0%-10.2%0.2×
Q2 FY0818 Oct 2007-3.8%-5.3%-9.7%0.2×
Q1 FY0819 Jul 2007+0.7%-1.9%-11.3%6.8×
Q4 FY0717 May 2007+0.6%-0.1%-0.1%3.8×
Average-0.6%-1.7%-2.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+10.6%
Profit YoY—
Interest cost YoY+15.4%
Revenue QoQ+1.2%
Profit QoQ-46.4%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+15.5%+15.4%+15.8%+14.8%+11.2%—
Profit——————

Key data

Open472.70
Day range465.00 – 477.95
52-week range278.20 – 687.20
From 52w high-31.8%
RSI (14)34.8
ATR (14)19.94
Volume16.7K
Avg volume (20D)54.5K
Rel volume0.31×
Volatility (1Y)49.6%
Turnover₹78.7L
Traded value (NSE)₹78.7L
VWAP471.32
SMA 50 / 200515.97 / 447.30
Price band20%

Delivery percentage

Latest · 20 Nov 202655.4%
20-day avg40.9%
1-year avg45.8%
Percentile (own history)47th
Range4.5–98.1%
Sessions3,629

Over the last 20 sessions UNICHEMLAB settled 40.9% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 45.8%, so recent sessions are running 5.0 points lower than usual. The latest session ranks higher than 47% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders26.2K · +3.2% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy134 days ago

Performance returns

1D1W1M3M6M1Y
Price-2.15%-5.97%-3.85%-9.21%+27.73%+0.61%

Valuation

Market cap₹3,302 Cr
Market cap (NSE)₹3,302 Cr
Free-float cap₹983 Cr
P/E (TTM)9.7
P/E (NSE)10.0
EPS (TTM)48.13
P/B1.2
Net margin (TTM)14.3%
Other income / PBT17.0%
ROE13.0%
Debt / equity0.17
Shares outstanding7.04Cr
Listed7 Feb 2001

Ownership

Promoter70.22%
Promoter Δ QoQ0.00 pp
Public29.78%
FII2.70%
DII9.40%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)521.2575.1632.6640.2
YoY chg-2.2%-2.1%+20.1%+10.6%
Net profit (₹ Cr)264.310.941.522.2
YoY chg+356.9%-79.4%——
Net margin50.7%1.9%6.6%3.5%
EPS37.471.556.613.14

Shareholding over time

By quarter

30 Sept 2026 · promoter 70.22% · public 29.78%
30 Sept 2021: promoter 50.93%31 Dec 2021: promoter 50.93%31 Mar 2022: promoter 50.93%30 Jun 2022: promoter 50.93%30 Sept 2022: promoter 50.93%31 Dec 2022: promoter 50.93%31 Mar 2023: promoter 50.93%30 Jun 2023: promoter 50.93%30 Sept 2023: promoter 70.21%31 Dec 2023: promoter 70.22%31 Mar 2024: promoter 70.22%30 Jun 2024: promoter 70.22%30 Sept 2024: promoter 70.22%31 Dec 2024: promoter 70.22%31 Mar 2025: promoter 70.22%30 Jun 2025: promoter 70.22%30 Sept 2025: promoter 70.22%31 Dec 2025: promoter 70.22%31 Mar 2026: promoter 70.22%30 Jun 2026: promoter 70.22%30 Sept 2026: promoter 70.22%
2021-092026-09
  • Promoter
  • Public and others
Promoter
70.22%
Public
29.78%
Promoter change
0.00 pp
Filed
13 Oct 2026
FII
2.70%
DII
9.40%
Promoter pledged
0.00%

Who the public is

Mutual funds
8.65%

-0.67 pp QoQ

Insurance
0.22%

0.00 pp QoQ

FPI
2.70%

+1.80 pp QoQ

Retail ≤ ₹2L
13.06%

-0.40 pp QoQ

HNI > ₹2L
1.84%

-0.28 pp QoQ

NRI
0.71%

+0.02 pp QoQ

Bodies corporate
0.33%

-0.07 pp QoQ

Shareholders
26,164

+3.2% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Ipca Laboratories LimitedPromoter · Corporate52.67%
Dr. Prakash Amrut ModyPromoter · Individual12.78%
Hdfc Small Cap FundMutual fund7.04%
Anita Prakash ModyPromoter · Individual1.88%
Dsp Healthcare FundMutual fund1.60%
Polunin Emerging Markets Small Cap Fund, LlcFPI1.58%
Suparna Prakash ModyPromoter · Individual1.35%
Supriya Prakash ModyPromoter · Individual1.35%
Investor Education And Protection Fund Authority Ministry Of Corporate AffairsOther1.06%
Dr. Prakash Amrut Mody - Suparna Mody Trust (Promoter Trust )Promoter · Other0.07%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 13 Sept 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2022-231₹4.00₹4.00
FY2021-221₹4.00₹4.00
FY2020-211₹4.00₹4.00
FY2019-201₹4.00₹4.00
FY2018-191₹5.00₹5.00
FY2017-181₹3.00₹3.00
FY2015-162₹4.00₹4.00
FY2014-151₹4.00₹4.00
FY2013-142₹8.50₹8.50
FY2012-131₹3.00₹3.00
Ex-dateRecord dateDeclaredAdjusted
1 Aug 2022—₹4.00₹4.00
22 Jul 2021—₹4.00₹4.00
20 Aug 2020—₹4.00₹4.00
18 Jul 2019—₹4.00₹4.00
19 Jul 2018—₹5.00₹5.00
13 Jul 2017—₹3.00₹3.00
17 Mar 2016—₹2.00₹2.00
2 Jul 2015—₹2.00₹2.00
3 Jul 2014—₹4.00₹4.00
23 Jan 2014—₹4.00₹4.00
11 Jul 2013—₹4.50₹4.50
13 Sept 2012—₹3.00₹3.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
6.6 years ago
Disclosures on record
46
33 open-market of the newest 46
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
24 Aug 2023VANDANA PANDEYEmployeeSell6.0K₹24.4L406.747.5K → 1.5K0.00%0.00 pp7(2)told 23 Aug 2023
23 Aug 2023Dilip Janardan KunkolienkarDirectorSell5.0K₹20.4L408.225.3K → 2790.00%0.00 pp7(2)told 23 Aug 2023
21 Aug 2023Dilip Janardan KunkolienkarDirectorSell5.0K₹20.4L407.4010.3K → 5.3K0.00%0.00 pp7(2)told 21 Aug 2023
17 Aug 2023Dilip Janardan KunkolienkarDirectorSell30.0K₹1.2Cr404.4440.3K → 10.3K0.01%-0.03 pp7(2)told 16 Aug 2023
16 Aug 2023JALESH BURYEEmployeeSell3.3K₹13.4L401.643.3K → —0.00%7(2)told 16 Aug 2023
9 Aug 2023Dilip Janardan KunkolienkarDirectorSell16.3K₹64.5L397.0056.5K → 40.3K0.06%-0.02 pp7(2)told 7 Aug 2023
2 Aug 2023Dilip Janardan KunkolienkarDirectorSell19.0K₹75.4L397.0375.5K → 56.5K0.08%-0.03 pp7(2)told 2 Aug 2023
27 Jul 2023VERA MAHAJANRelativeSell2.8K₹10.7L378.132.8K → —0.00%7(2)told 27 Jul 2023
27 Jul 2023ANAND MAHAJANDirectorSell3.0K₹11.5L378.553.0K → —0.00%7(2)told 27 Jul 2023
25 Jul 2023Vera Anand MahajanRelativeSell4.0K₹15.1L378.116.8K → 2.8K0.00%0.00 pp7(2)told 25 Jul 2023
25 Jul 2023ANAND Y MAHAJANDirectorSell2.0K₹7.6L378.085.0K → 3.0K0.00%0.00 pp7(2)told 25 Jul 2023
21 Jul 2023ANAND Y MAHAJANDirectorSell1.0K₹3.8L377.066.0K → 5.0K0.00%0.00 pp7(2)
21 Jul 2023Vera Anand MahajanRelativeSell4.0K₹15.1L377.4910.8K → 6.8K0.00%0.00 pp7(2)told 21 Jul 2023
21 Jul 2023ANAND Y MAHAJANDirectorSell1.0K₹3.8L377.797.0K → 6.0K0.00%0.00 pp7(2)told 20 Jul 2023
7 Jun 2023AAKIL A MAHAJANRelativeSell6.3K₹23.5L372.006.3K → —0.00%7(2)told 6 Jun 2023
7 Jun 2023Vera Anand MahajanRelativeSell2.8K₹10.2L371.9813.6K → 10.8K0.01%-0.00 pp7(2)told 6 Jun 2023
7 Jun 2023ANAND Y MAHAJANDirectorSell1.8K₹6.5L371.868.8K → 7.0K0.00%0.00 pp7(2)told 6 Jun 2023
6 Jun 2023Vera Anand MahajanRelativeSell2.8K₹10.4L371.1616.4K → 13.6K0.01%-0.00 pp7(2)told 5 Jun 2023
6 Jun 2023ANAND Y MAHAJANDirectorSell1.8K₹6.7L371.6910.6K → 8.8K0.00%0.00 pp7(2)told 5 Jun 2023
5 Jun 2023Vera Anand MahajanRelativeSell7.0K₹25.8L371.4923.3K → 16.4K0.02%-0.01 pp7(2)told 3 Jun 2023
5 Jun 2023ANAND Y MAHAJANDirectorSell4.5K₹16.5L371.3715.0K → 10.6K0.01%-0.00 pp7(2)told 3 Jun 2023
1 Jun 2023Mrs Vidhya AnantharamanRelativeSell7.5K₹27.7L371.637.5K → —0.00%7(2)told 31 May 2023
31 May 2023Rupande ShahRelativeSell26.5K₹99.2L374.4826.5K → —0.00%7(2)told 30 May 2023
31 May 2023PRAFUL ANUBHAIDirectorSell682₹2.5L372.11782 → 1000.00%0.00 pp7(2)told 30 May 2023
1 Apr 2021Mrs Vidhya AnantharamamRelativeBuy7.5K₹23.2L311.10— → 7.5K0.01%7(2)told 1 Apr 2021
31 Mar 2020Shwetambari Mody TrustPromoterBuy26.3K₹37.5L142.6115.0K → 41.3K0.06%+0.04 pp7(2)told 31 Mar 2020
31 Mar 2020Suparna Mody TrustPromoterBuy34.5K₹49.7L143.8917.5K → 52.0K0.07%+0.05 pp7(2)told 31 Mar 2020
31 Mar 2020Supriya Mody TrustPromoterBuy30.0K₹42.3L141.3115.1K → 45.1K0.06%+0.04 pp7(2)told 31 Mar 2020
31 Mar 2020Dr Prakash A. ModyPromoterBuy43.7K₹63.6L145.453.25Cr → 3.25Cr46.16%+0.06 pp7(2)told 31 Mar 2020
28 Mar 2020Shwetambari Mody TrustPromoterBuy15.0K₹18.0L120.22— → 15.0K0.02%7(2)told 27 Mar 2020
28 Mar 2020Suparna Mody TrustPromoterBuy17.5K₹21.3L121.76— → 17.5K0.02%7(2)told 27 Mar 2020
28 Mar 2020Supriya Mody TrustPromoterBuy15.1K₹18.3L120.93— → 15.1K0.02%7(2)told 27 Mar 2020
28 Mar 2020Dr Prakash A. ModyPromoterBuy36.3K₹43.6L120.133.24Cr → 3.25Cr46.10%+0.05 pp7(2)told 27 Mar 2020

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 9 Jul 2026

CSV
12 of 27 deals
By year
DateDealClientQuantityPriceValue
9 Jul 2026Buy · bulkPOLUNIN EMERGING MARKETS SMALL CAP FUND LLC6.01L646.44₹38.8Cr
11 Jun 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED10.63L486.94₹51.8Cr
11 Jun 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED10.63L486.70₹51.7Cr
11 Jun 2026Sell · bulkJUNOMONETA FINSOL PRIVATE LIMITED9.24L488.31₹45.1Cr
11 Jun 2026Buy · bulkJUNOMONETA FINSOL PRIVATE LIMITED9.17L487.89₹44.7Cr
11 Jun 2026Sell · bulkMICROCURVES TRADING PRIVATE LIMITED8.64L489.48₹42.3Cr
11 Jun 2026Buy · bulkMICROCURVES TRADING PRIVATE LIMITED8.64L489.27₹42.3Cr
11 Jun 2026Sell · bulkIRAGE BROKING SERVICES LLP7.59L487.66₹37.0Cr
11 Jun 2026Buy · bulkIRAGE BROKING SERVICES LLP7.10L485.58₹34.5Cr
11 Jun 2026Buy · bulkQE SECURITIES LLP6.15L490.39₹30.2Cr
11 Jun 2026Buy · bulkELIXIR WEALTH MANAGEMENT PRIVATE LIMITED6.16L488.36₹30.1Cr
11 Jun 2026Sell · bulkELIXIR WEALTH MANAGEMENT PRIVATE LIMITED6.01L489.58₹29.4Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Open positions in NSE’s securities lending and borrowing market: shares borrowed and not yet returned, the usual way to hold a short beyond the day.

Exchange surveillance

20 Nov 2026
  • High-low range > 100% in 6 months · since 8 Sept 2026 — One of the criteria NSE’s surveillance watches: high-low range > 100% in 6 months.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations434.4431.7446.4462.2533.1587.2526.6579.0521.2575.1632.6640.2
Other income11.36.23.98.813.69.36.821.011.823.515.615.4
Total income445.7437.9450.3471.0546.7596.4533.4599.9533.0598.6648.2655.6
Total expenses429.7438.1435.3438.0484.9538.6542.4552.5515.1567.4599.2604.0
└ Finance costs5.64.64.04.86.85.56.58.27.49.46.67.7
└ Depreciation27.927.228.328.530.529.731.831.531.330.629.930.5
Profit before tax84.0(125.9)15.033.061.957.8(9.0)(10.8)293.418.849.027.4
Tax expense(0.0)3.45.72.54.04.81.51.129.17.97.55.2
Net profit84.0(129.3)9.330.557.953.0(10.5)(11.9)264.310.941.522.2
EPS11.93-18.371.314.348.227.52-1.49-1.6937.541.556.613.16
Net margin19.34%-29.95%2.07%6.60%10.85%9.02%-1.99%-2.05%50.71%1.90%6.56%3.47%
PBT margin19.33%-29.16%3.36%7.14%11.60%9.84%-1.71%-1.87%56.30%3.27%7.74%4.28%
Tax rate-0.03%—38.29%7.58%6.47%8.36%——9.93%41.94%15.35%18.82%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets3,193.03,069.93,169.33,311.03,569.43,556.23,737.43,907.6
Current assets1,588.51,532.31,694.21,823.52,029.52,026.02,197.32,362.2
└ Cash & equivalents183.863.1150.9187.889.6178.0289.5157.0
└ Other bank balances1.61.43.410.328.115.45.23.4
└ Current investments1.51.61.30.00.00.00.00.0
└ Trade receivables588.6615.0610.4630.4778.8777.9828.6985.8
└ Inventories625.2637.5704.7837.5988.7977.9975.01,083.5
Total equity2,435.32,408.02,362.42,400.72,450.62,434.82,717.42,781.4
└ Attributable to owners2,435.32,408.02,362.42,400.72,450.62,434.82,717.42,781.4
└ Non-controlling interest0.00.00.0—0.0——0.0
└ Share capital14.114.114.114.114.114.114.114.1
Borrowings297.4276.0219.1268.3430.0473.5468.8474.6
└ Current233.7225.0180.9242.8369.2430.2429.7442.2
└ Non-current63.650.938.225.560.843.339.132.4
Trade payables290.7214.4299.4361.8402.6318.4356.6453.7
Current liabilities639.6553.9707.9819.6992.01,016.6885.91,000.7
Total liabilities757.7661.9806.9910.31,118.81,121.41,020.01,126.1
Net debt110.5209.863.570.2312.3280.0174.1314.2
Debt / equity0.120.110.090.110.180.190.170.17
Current ratio2.482.772.392.222.051.992.482.36

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow(85.1)(77.6)16.744.8(7.0)99.43.6(68.1)
└ Capex(44.3)(10.9)(22.5)(42.6)(137.4)(58.6)(123.0)(55.2)
Free cash flow(129.4)(88.5)(5.9)2.3(144.4)40.8(119.4)(123.2)
Investing cash flow202.8(8.8)50.4(46.5)(241.2)(37.6)192.1(51.7)
Financing cash flow(81.3)(36.7)(106.3)37.9183.825.91.9(11.2)
└ Dividends paid(28.3)(0.2)(0.2)(0.3)(0.3)(0.3)0.0(0.2)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash38.2(120.6)(39.2)36.9(65.2)88.5199.9(132.5)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

UNICHEMLAB at a glance

  • UNICHEMLAB closed at ₹468.95 on 20 Nov 2026, -2.15% on the day, +0.6% over one year, 31.8% below its 52-week high of ₹687.2.
  • Delivery was 55.4% of traded quantity on 20 Nov 2026, the 47th percentile of its own 3,629 sessions with a reading (20-session average 40.9%, 1-year average 45.8%).
  • Market capitalisation is ₹3,302 crore at a trailing P/E of 9.7 (trailing EPS ₹48.13).
  • Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹640 crore (+10.6% year on year), net profit ₹22 crore; the price moved +0.4% on the first session after.
  • Promoters held 70.22% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 29 Jan 2027 and 6 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE351A01035
SeriesEQ
Listed7 Feb 2001
NSE market cap · 17 Nov 2026₹3,390 Cr
Free-float market cap (NSE)₹974 Cr
Shares outstanding (NSE)7.04Cr
History from10 Jan 1995
Sessions7,578

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.